Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.04 (+1.76%)
As of: Nov 11, 2026 · 3:59 PM EST

Artelo Biosciences (ARTL) Share-based Compensation (2017 - 2026)

Updated

Artelo Biosciences (ARTL) recorded Share-based Compensation of $401,000 in Q1 2026, up 108.9% from $192,000 a year earlier and up 9.0% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Share-based Compensation (2017 - 2026) Analysis & Trends

On a TTM basis, Artelo Biosciences' Share-based Compensation came in at $1.35 million as of Mar 31, 2026, up 69.5% year-over-year; for FY2025, it came in at $1.14 million, up 39.6% from FY2024.

  • Annual Share-based Compensation has a five-year compound annual growth rate of 24.6% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $818,000 in FY2024 (-19.8%), $1.02 million in FY2023 (-58.5%), $2.46 million in FY2022 and $1.53 million in FY2021 (+301.8%).
  • Quarterly Share-based Compensation has ranged from $150,000 in Q2 2025 to $624,000 in Q1 2022 over the past five years.
  • On a year-over-year basis, Share-based Compensation has increased for three consecutive quarters, with growth averaging 29.8% over the last eight quarters.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 224.3% in Q2 2021, against a decline of 64.0% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $368,000 (Q4 2025), $432,000 (Q3 2025) and $150,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 357.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 160.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 234.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 362.00 Mn
10 Artelo Biosciences 49.32 Mn 32.53 Mn - 570,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 570,000.00
Mar 31, 2026 401,000.00
Dec 31, 2025 368,000.00
Sep 30, 2025 432,000.00
Jun 30, 2025 150,000.00
Mar 31, 2025 192,000.00
Dec 31, 2024 201,000.00
Sep 30, 2024 209,000.00
Jun 30, 2024 195,000.00
Mar 31, 2024 213,000.00
Dec 31, 2023 219,000.00
Sep 30, 2023 222,000.00
Jun 30, 2023 225,000.00
Mar 31, 2023 354,000.00
Dec 31, 2022 608,000.00
Sep 30, 2022 607,000.00
Jun 30, 2022 619,000.00
Mar 31, 2022 624,000.00
Nov 30, 2021 571,000.00
Feb 28, 2021 341,817.00
API Access

Artelo Biosciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ARTL&period=max&api_key=YOUR_API_KEY